title: Refractory chronic urticaria treated effectively with the protease inhibitors, nafamostat mesilate and camostat mesilate.
authors.forename: Shunsuke
authors.initials: S
authors.lastname: Takahagi
authors.forename: Hajime
authors.initials: H
authors.lastname: Shindo
authors.forename: Makiko
authors.initials: M
authors.lastname: Watanabe
authors.forename: Yoshikazu
authors.initials: Y
authors.lastname: Kameyoshi
authors.forename: Michihiro
authors.initials: M
authors.lastname: Hide
mesh_terms: D000328:Adult; D001550:Benzamidines; D002908:Chronic Disease; D004359:Drug Therapy, Combination; D004952:Esters; D005260:Female; D016670:Gabexate / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006146:Guanidines / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011480:Protease Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome; D014581:Urticaria / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology
chemical_list: D001550:Benzamidines; D004952:Esters; D006146:Guanidines; D011480:Protease Inhibitors; C034532:camostat; D016670:Gabexate; C032855:nafamostat